title: Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Formica
authors.forename: Eugenio
authors.initials: E
authors.lastname: Montefusco
authors.forename: Mario
authors.initials: M
authors.lastname: Roselli
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized